Stockscreener 앱 받기
25.89
4.40%
1.09
시장 영업 전:
25.89
Staar Surgical Co 주식(STAA)의 최신 뉴스
Broadwood sees $50/share path for STAAR Surgical as merger battle nears voting day - Investing.com India
Defender Capital to vote against STAAR Surgical sale to Alcon By Investing.com - Investing.com Nigeria
Defender Capital to vote against STAAR Surgical sale to Alcon - Investing.com India
STAAR urges stockholders to vote for Alcon merger amid proxy battle - Investing.com Nigeria
Broadwood urges shareholders to reject Alcon’s bid for STAAR - Investing.com
Big STAAR investor fights Alcon buyout, says shares should hit $50 - Stock Titan
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value | ALC Stock News - Stock Titan
Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory - marketscreener.com
STAAR Surgical (NASDAQ: STAA) investor Yunqi Capital urges no vote on Alcon deal - Stock Titan
ISS recommends STAAR Surgical deal, but warns shareholders have reason to object - Investing.com
Yunqi Capital to vote against revised Alcon-STAAR merger offer By Investing.com - Investing.com South Africa
Yunqi Capital to vote against revised Alcon-STAAR merger offer - Investing.com
Yunqi Capital says remains opposed to STAAR’s proposed merger with Alcon - TipRanks
Midday Stock Roundup: Shares of Aeon Biopharma, Staar Surgical Up - Orange County Business Journal
5.1% STAAR owner fights Alcon deal, arguing company is worth more - Stock Titan
STAAR Surgical (NASDAQ:STAA) Shares Gap UpTime to Buy? - MarketBeat
Alcon raises STAAR Surgical acquisition offer to $30.75 per share By Investing.com - Investing.com Nigeria
Alcon (NYSE: ALC) $30.75-per-share STAAR bid gains support from analysts and ISS - Stock Titan
Proxy firms raise concerns over STAAR Surgical’s proposed sale to Alcon - Investing.com Canada
Proxy firms raise concerns over STAAR Surgical’s proposed sale to Alcon By Investing.com - Investing.com South Africa
Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon - FinancialContent
Using the ICL as a supplementary IOL - EyeWorld
STAAR Surgical (STAA) Gains as ISS Backs Alcon's Improved Offer - GuruFocus
Battle for STAAR Surgical intensifies as Glass Lewis reiterates stance ’against’ - Investing.com Australia
Broadwood urges STAAR Surgical (NASDAQ: STAA) vote against Alcon sale - Stock Titan
Midday Stock Roundup: Rivian Rises on Chip, Models - Orange County Business Journal
STAAR Surgical (STAA) Faces Investor Pushback on Alcon Offer - GuruFocus
Glass Lewis Reaffirms its Recommendations to Shareholders of STAAR - marketscreener.com
Glass Lewis reaffirms opposition to Alcon’s STAAR acquisition bid - Investing.com
Glass Lewis reaffirms opposition to Alcon’s STAAR acquisition bid By Investing.com - Investing.com Australia
STAAR Surgical stock jumps 10% after Alcon sweetens buyout offer — investor says deal is 'worth substantially more' - MSN
STAAR Surgical accuses activist Broadwood of ’misinformation campaign’ - Investing.com
STAAR Surgical Rebuts Investor Claims Over Alcon Deal Process - Finimize
Why STAAR Surgical (STAA) Stock Is Up Today - Finviz
STAAR addresses activist investor claims about go-shop process By Investing.com - Investing.com Australia
STAAR Surgical (STAA): Assessing Valuation After Recent Share Price Weakness - Yahoo Finance UK
Broadwood continues opposition to STAAR’s acquisition by Alcon - Investing.com
Canaccord Genuity Raises Price Target for STAA, Reaffirms Hold R - GuruFocus
STAAR Surgical falls as Yunqi Capital reiterates opposition to merger with Alcon - Investing.com India
STAAR Surgical's Top Investors Reject Sweetened Alcon Offer, Cite Flawed Sale Process - Benzinga
STAAR Surgical (NASDAQ:STAA) Shares Gap DownWhat's Next? - MarketBeat
Alcon sweetens offer for Staar, major shareholders still unimpressed - BioWorld MedTech
Yunqi Capital Comments on STAAR Surgical?s Go-Shop Process - marketscreener.com
STAAR Surgical holder Yunqi Capital still against sale to Alcon (STAA:NASDAQ) - Seeking Alpha
STAAR Surgical Engages with its Employees - marketscreener.com
STAAR Surgical Acquisition by Alcon Opposed by Investor Yunqi Capital - marketscreener.com
Yunqi Capital opposes Alcon’s revised offer for STAAR Surgical - Investing.com
Yunqi Capital opposes Alcon’s revised offer for STAAR Surgical By Investing.com - Investing.com Australia
Yunqi Capital comments on Staar Surgical's go-shop process and Alcon's revised offer - marketscreener.com
Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer - marketscreener.com
Switzerland: Alcon agrees best and final offer with STAAR Surgical - Investors in Healthcare
Alcon lifts bid for medical technology firm Staar to $1.6 billion - WHTC
Mergers and acquisitions - TradingView
STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know - Yahoo Finance
Alcon bumps STAAR Surgical bid to $30.75, but Broadwood remains vehemently against - Investing.com
STAAR Surgical Stock Jumps 10% After Alcon Sweetens Buyout Offer — Investor Says Deal Is ‘Worth Substantially More’ - Stocktwits
Broadwood continues to oppose STAAR sale to Alcon despite price bump By Investing.com - Investing.com UK
Swiss eyecare giant Alcon lifts bid for rival Staar - Reuters
Alcon (NYSE: ALC) Faces Broadwood Pushback on Raised $30.75 STAAR Deal Offer - Stock Titan
1.26%
1.42%
자본화:
|
볼륨(24시간):